These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1047 related items for PubMed ID: 19760047

  • 1. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S, Romero LM, Haigh PI, DiFronzo LA.
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [Abstract] [Full Text] [Related]

  • 7. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A, Newcombe RG, Chhabra A, Mansel RE.
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [Abstract] [Full Text] [Related]

  • 8. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
    Mustać E, Matusan-Ilijas K, Marijić B, Smokvina M, Jonjić N.
    Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
    [Abstract] [Full Text] [Related]

  • 9. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.
    J Surg Oncol; 2004 Oct 01; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [Abstract] [Full Text] [Related]

  • 10. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M, Canavese G, Lionetto R, Catturich A, Vecchio C, Sapino A, Friedman D, Cafiero F.
    Eur J Surg Oncol; 2006 Mar 01; 32(2):143-7. PubMed ID: 16300921
    [Abstract] [Full Text] [Related]

  • 11. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.
    Fan YG, Tan YY, Wu CT, Treseler P, Lu Y, Chan CW, Hwang S, Ewing C, Esserman L, Morita E, Leong SP.
    Ann Surg Oncol; 2005 Sep 01; 12(9):705-11. PubMed ID: 16079953
    [Abstract] [Full Text] [Related]

  • 12. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.
    J Surg Oncol; 2004 Mar 01; 85(3):102-11. PubMed ID: 14991881
    [Abstract] [Full Text] [Related]

  • 13. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
    Davit FE, Gatmaitan P, Garguilo G.
    Am Surg; 2008 May 01; 74(5):423-7. PubMed ID: 18481500
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
    Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, Feig BW, Ross MI, Ames FC, Singletary SE, Buchholz TA, Valero V, Hunt KK.
    Cancer; 2005 Apr 15; 103(8):1581-6. PubMed ID: 15747375
    [Abstract] [Full Text] [Related]

  • 15. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.
    J Surg Oncol; 2006 Feb 01; 93(2):109-19. PubMed ID: 16425290
    [Abstract] [Full Text] [Related]

  • 16. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.
    Takei H, Kurosumi M, Yoshida T, Ishikawa Y, Hayashi Y, Ninomiya J, Tozuka K, Oba H, Inoue K, Nagai S, Saito Y, Kazumoto T, Saitoh J, Tabei T.
    Breast Cancer; 2010 Feb 01; 17(1):9-16. PubMed ID: 19701679
    [Abstract] [Full Text] [Related]

  • 17. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H, Suzuki M, Kamio M, Kato K, Kawase K, Toriumi Y, Takeyama H, Fukushima H, Morikawa T, Uchida K.
    Oncol Rep; 2011 Apr 01; 25(4):1109-15. PubMed ID: 21308353
    [Abstract] [Full Text] [Related]

  • 18. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.
    Indian J Surg Oncol; 2010 Jan 01; 1(1):59-67. PubMed ID: 22930620
    [Abstract] [Full Text] [Related]

  • 19. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
    Takeshita T, Tsuda H, Moriya T, Yamasaki T, Asakawa H, Ueda S, Sato K, Aida S, Tamai S, Matsubara O, Hase K, Yamamoto J.
    Ann Surg Oncol; 2012 Apr 01; 19(4):1160-6. PubMed ID: 21989659
    [Abstract] [Full Text] [Related]

  • 20. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK.
    Cancer; 2007 Apr 01; 109(7):1255-63. PubMed ID: 17330229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.